我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
41
批准总数
监管机构
3
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
NMPA
National Medical Products Administration
FDA
Food and Drug Administration
27
CANADA
Health Canada
11
- Dr. Kandiraju Venkata Sitaram Rao has resigned from his position as Joint Managing Director and CEO of Granules India Limited, effective July 31, 2025. - The pharmaceutical executive brings over 29 years of experience in manufacturing, R&D, and business operations to his departure from the Indian generic drug manufacturer. - Granules India has acknowledged the resignation and is implementing measures to ensure a seamless leadership transition over the coming weeks. - Dr. Rao previously held senior leadership positions at PI Industries, Dr. Reddy's Laboratories, Jubilant Life Sciences, and Gujarat Heavy Chemicals Ltd.
